Recombinant Human MCP-4 (CCL13)|重組人單核細(xì)胞趨化蛋白-4
產(chǎn)品名稱: Recombinant Human MCP-4 (CCL13)|重組人單核細(xì)胞趨化蛋白-4
產(chǎn)品型號(hào): C22-204-13
產(chǎn)品展商: PERFEMIKER
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
Recombinant Human MCP-4 (CCL13)|重組人單核細(xì)胞趨化蛋白-4現(xiàn)貨促銷，>96% by SDS-PAGE and HPLC analyses.
Recombinant Human MCP-4 (CCL13)|重組人單核細(xì)胞趨化蛋白-4
的詳細(xì)介紹
產(chǎn)品名稱：Recombinant Human MCP-4 (CCL13)|重組人單核細(xì)胞趨化蛋白-4
單 位：支
Recombinant Human MCP-4 (CCL13)|重組人單核細(xì)胞趨化蛋白-4，國(guó)產(chǎn)細(xì)胞因子,cytokine
產(chǎn)品詳細(xì)介紹：
C22-204-13 5μg/￥500 20μg/￥1000 1mg/詢價(jià)
Purity:
>96% by SDS-PAGE and HPLC analyses.
Biological Activity:
Fully biologically active when compared to standard. Determined by its ability to chemoattract human monocytes using a concentration range of 10.0-100.0 ng/ml.
Storage:
This lyophilized preparation is stable at 2-8°C, but should be kept at -20°C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8°C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20°C to -70°C. Avoid repeated freeze/thaw cycles.
